key: cord-0976965-49lnfe3k
authors: Srichatrapimuk, Sirawat; Chookajorn, Thanat; Kochakarn, Theerarat; Kirdlarp, Suppachok; Pasomsu, Ekawat; Chantratita, Wasun; Iamsirithaworn, Sopon; Kunakorn, Mongkol; Thitithanyanont, Arunee; Sungkanuparph, Somnuek; Phuphuakrat, Angsana
title: SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
date: 2022-02-02
journal: Travel Med Infect Dis
DOI: 10.1016/j.tmaid.2022.102271
sha: 2c557380d7122c9ea61a043634036cbaba6fd0a4
doc_id: 976965
cord_uid: 49lnfe3k

BACKGROUND: During the current coronavirus disease 2019 (COVID-19) pandemic, many countries require travellers to undergo a reverse transcription-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before travelling across borders. However, in persons having recovered from COVID-19, RT-PCR positivity can persist for an extended period. MATERIALS AND METHODS: We describe three cases who sought fit-to-fly certificates in Thailand during the period free of local transmission but were tested positive for RT-PCR for SARS-CoV-2. All had returned from a country with an active outbreak of COVID-19. Their clinical courses are described; positive nasopharyngeal swab samples were processed for viral isolation and whole-genome sequencing (WGS); and serology as well as neutralizing antibody were assessed. The contact tracing was carried out for determining evidence of indigenous transmission among close contacts of those three cases. RESULTS: All three cases were completely asymptomatic. Chest computerized tomography was not compatible with COVID-19 pneumonia; cell cultures failed to rescue replication-competent virus; WGS revealed fragmented viral genetic material from nasopharyngeal swab samples; and serological tests demonstrated stable levels of antibodies, together with the presence of neutralizing antibody, suggesting past infection with negligible transmission risk. Contact tracing identified no transmission in high-risk close contact individuals. CONCLUSION: RT-PCR positivity for SARS-CoV-2 might detect fragmented viral genome. Issuance of a travel certificate in these circumstances is problematic. Serology tests can help to define past infection. A practical acceptable set of guidelines for issuance of a COVID-19 safety travel certification is a necessity.

An outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, in 2 December 2019 and eventually becomes a pandemic [1] . Thailand is the first country outside 3 China reporting a COVID-19 case in early January 2020 [2, 3] . Following an initial phase of the 4 first wave of COVID-19 outbreak, local transmission was successfully contained on 26 May 5 2020 through a country-wide implementation of measures to curb the spread of the disease, 6 namely, lockdown, active case-finding and prompt case isolation [4] . The country later faced the 7 second wave of the local outbreak in mid-December 2020. 8 An important control measure after the containment of in-country outbreak at the time 9 was a mandatory 14-day quarantine of inbound travellers at the country's ports of entry, during which COVID-19 symptoms are monitored and nasopharyngeal (NP) swabs are collected for 11 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-12 polymerase chain reaction (RT-PCR) assay between day 3 and 5, with a repeat test one week 13 later [5] . This measure has helped to prevent inbound travellers with previously undiagnosed 14 COVID-19 to introduce the virus into the country. 15 Many countries currently require a negative RT-PCR test for SARS-CoV-2 for issuance 16 of a 'fit-to-fly' health certificate prior to travelling [6] [7] [8] . However, in August 2020, when The cases were individuals who returned to Thailand and tested negative for SARS-CoV-2 2 by RT-PCR using an Allplex™ 2019-nCoV Assay (Seegene, Seoul, South Korea) on two 3 occasions during the mandatory 14-day quarantine program, but were tested positive for SARS- CoV-2 by RT-PCR at Ramathibodi Hospital, Bangkok when they sought a fit-to-fly health 5 certificate.

The study protocol was reviewed and approved by the Ethical Clearance Committee on Ortho anti-S1 protein total antibody assay, and positive cut-off >1.1, borderline 0.8-1.1 and 1 negative cut-off <0.8 for Euroimmun anti-S protein IgA and IgG assays. 

In the three cases, at hospital admission, anti-SARS-CoV-2 IgG but not IgM was 19 detected, while IgA titres were borderline in Case 1 and positive in Cases 2 and 3 (Table 1) . In order to determine if these three cases were able to transmit SARS-CoV-2 to others, 4 viral cultures from NP swabs in Vero E6 cells were performed but no replication-competent 5 virus was obtained. In addition, WGS of NP swab specimens using an ARTIC multiplex 6 enrichment method demonstrated mostly fragmented genomes, with the presence of <15% of the 7 intact genome (Figure 2) , suggesting viral RNA detected in NP swabs from the three cases did 8 not come from the intact virus. 

The novel Chinese coronavirus (2019-nCoV) 15 infections: challenges for fighting the storm

Self-18 assessment of the Thai Department of Disease Control's communication for international

The authors declare no conflicts of interest.

All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated.

The study was funded by Better Health Programme National Research Council of Thailand (NRCT); National Science and Technology Development Agency (NSTDA); Ramathibodi Foundation; and Thailand Center of Excellence for Life Sciences (TCELS).